Skip to main content
رجوع
MOH logo

Molina Healthcare, Inc.

جودة البيانات: 100%
MOH
NYSE Healthcare Medical - Healthcare Plans
KWD 139.84
▼ KWD 1.90 (-1.34%)
القيمة السوقية: 7.20B
نطاق اليوم
KWD 136.45 KWD 144.31
نطاق 52 أسبوعًا
KWD 121.06 KWD 359.97
حجم التداول
781,979
متوسط 50 يوم / 200 يوم
KWD 160.65 / KWD 181.77
الإغلاق السابق
KWD 141.74

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 15.3 0.2
P/B 1.8 3.0
ROE % 11.0 3.6
Net Margin % 1.0 3.8
Rev Growth 5Y % 13.1 9.7
D/E 1.0 0.2

السعر المستهدف للمحللين

Hold
KWD 175.64 +25.6%
Low: KWD 124.00 High: KWD 310.00
مكرر الربحية المستقبلي
27.74
ربحية السهم المستقبلية
KWD 5.04
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
44.85B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 25.38
KWD 23.65 – KWD 27.55
 52.76B 2
FY2029 KWD 19.10
KWD 17.80 – KWD 20.73
 50.20B 2
FY2028 KWD 12.34
KWD 10.37 – KWD 13.34
 49.27B 4

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-05 KWD 0.43 -KWD 2.75 -739.5%
2025-10-22 KWD 3.97 KWD 1.84 -53.7%
2025-07-23 KWD 5.62 KWD 5.48 -2.5%
2025-04-23 KWD 5.97 KWD 6.08 +1.8%
2025-02-05 KWD 5.74 KWD 5.05 -12.0%
2024-10-23 KWD 5.81 KWD 6.01 +3.4%
2024-07-24 KWD 5.50 KWD 5.86 +6.5%
2024-04-24 KWD 5.59 KWD 5.73 +2.5%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 13.09% annually over 5 years — strong growth
Earnings declined -59.97% over the past year
ROE of 11.02% — decent returns on equity
Negative free cash flow of -636.00M
Capital efficient — spends only 0.22% of revenue on capex

النمو

Revenue Growth (5Y)
13.09%
Revenue (1Y)11.75%
Earnings (1Y)-59.97%
FCF Growth (3Y)N/A

الجودة

Return on Equity
11.02%
ROIC7.30%
Net Margin1.04%
Op. Margin1.72%

الأمان

Debt / Equity
0.97
Current Ratio1.69
Interest Coverage4.07

التقييم

P/E Ratio
15.26
Forward P/E27.74
P/B Ratio1.77
EV/EBITDA8.84
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11.75% Revenue Growth (3Y) 15.47%
Earnings Growth (1Y) -59.97% Earnings Growth (3Y) -34.23%
Revenue Growth (5Y) 13.09% Earnings Growth (5Y) -8.01%
Profitability
Revenue (TTM) 45.43B Net Income (TTM) 472.00M
ROE 11.02% ROA 3.03%
Gross Margin 8.97% Operating Margin 1.72%
Net Margin 1.04% Free Cash Flow (TTM) -636.00M
ROIC 7.30% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.97 Current Ratio 1.69
Interest Coverage 4.07
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 15.26 Forward P/E 27.74
P/B Ratio 1.77 P/S Ratio 0.16
PEG Ratio -0.33 Forward PEG N/A
EV/EBITDA 8.84 Fwd EV/EBITDA 3.81
Forward P/S 0.16 Fwd Earnings Yield 3.60%
FCF Yield -8.83%
Market Cap 7.20B Enterprise Value 6.90B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 45.43B 40.65B 34.07B 31.97B 27.77B
Net Income 472.00M 1.18B 1.09B 792.00M 659.00M
EPS (Diluted) 8.92 20.42 18.78 13.54 11.25
Gross Profit 4.08B 4.74B 4.33B 3.93B 3.28B
Operating Income 781.00M 1.71B 1.57B 1.17B 1.02B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 15.56B 15.63B 14.89B 12.31B 12.21B
Total Liabilities 11.50B 11.13B 10.68B 9.35B 9.58B
Shareholders' Equity 4.07B 4.50B 4.22B 2.96B 2.63B
Total Debt 3.95B 3.12B 2.39B 2.39B 2.39B
Cash & Equivalents 4.25B 4.66B 4.85B 4.01B 4.44B
Current Assets 12.44B 12.77B 12.54B 10.08B 10.06B
Current Liabilities 7.37B 7.90B 8.17B 6.86B 7.05B

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#382 of 619
28

النشاط الأخير

دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026